Deep Dive: FDA approves antibody to protect newborns from RSV
News 12 spoke with Dr. Harpreet Pall, chair and professor of the Department of Pediatrics at Hackensack Meridian School of Medicine.
News 12 Staff
•
Jul 18, 2023, 2:44 AM
•
Updated 287 days ago
Share:
More Stories
0:26
Want to support women-owned businesses? 5 ways to help you find shops during Women’s History Month
43ds ago4:03
DEEP DIVE: Marking the 60th anniversary of Martin Luther King Jr.'s 'I Have a Dream' speech
243ds ago4:02
Deep Dive: Retired superintendent shares insight on career and challenges in schools
311ds ago3:42
Deep Dive: Juneteenth commemorations planned across New Jersey
318ds ago3:32
Deep Dive: How wildfire smoke can have lasting effects on people
327ds ago3:45
Deep Dive: Families of 9/11 victims condemn PGA for merger with LIV Golf
328ds ago0:26
Want to support women-owned businesses? 5 ways to help you find shops during Women’s History Month
43ds ago4:03
DEEP DIVE: Marking the 60th anniversary of Martin Luther King Jr.'s 'I Have a Dream' speech
243ds ago4:02
Deep Dive: Retired superintendent shares insight on career and challenges in schools
311ds ago3:42
Deep Dive: Juneteenth commemorations planned across New Jersey
318ds ago3:32
Deep Dive: How wildfire smoke can have lasting effects on people
327ds ago3:45
Deep Dive: Families of 9/11 victims condemn PGA for merger with LIV Golf
328ds agoThe FDA approved an antibody to protect newborns from RSV.
It binds to the virus and blocks it from infecting health cells.
The antibody is not a vaccine for the respiratory virus: it is given as a single injection before RSV season, which usually peaks in the fall and winter.
News 12 spoke with Dr. Harpreet Pall, chair and professor of the Department of Pediatrics at Hackensack Meridian School of Medicine.
He discusses what the medical breakthrough means for parents.
